Latest News

Search News
Categories
Archives
SNPnexus: Assessing the impact of genetic variation

30th August 2018

A team of researchers from BCI’s Centre for Molecular Oncology, led by Prof Claude Chelala, have made new developments to SNPnexus- a computational tool that allows for the assessment of the functional effect of sequence variants within the genome.

Read more

Researchers identify new mechanism implicated in lung cancer progression

7th August 2018

A new study performed by researchers from BCI led by Dr Tyson Sharp, Lead of the Centre for Molecular Oncology, has identified a novel mechanism implicated in the development of lung adenocarcinoma (the most common type of non-small cell lung cancer), mediated by the loss of a gene called LIMD1.

Read more

Pancreatic Cancer UK Grand Challenge

27th July 2018

Our Director, Prof Nicholas Lemoine, and a team of researchers from the BCI and King’s College London have been awarded the Pancreatic Cancer UK (PCUK) Grand Challenge- PCUK’s largest ever research fund. The grant will be used for the development of a type of immunotherapy, known as CAR T cell therapy, to treat pancreatic cancer. Leanne Reynolds, Head of Research at PCUK […]

Read more

CRUK Gibraltar Committee visit the BCI

18th July 2018

We were recently visited by two members of the CRUK Gibraltar Committee, Giovi and Deborah, who came to the BCI for a laboratory tour with Dr Ana Rio-Machin, a postdoctoral researcher in the Centre for Haemato-Oncology. Ana’s research focuses on leukaemia, a type of blood cancer in which patients present an abnormal growth of white blood cells.

Read more

Uncovering the evolutionary history of IBD-associated colorectal cancer

11th July 2018

A team of researchers from the BCI, led by Prof Trevor Graham, Lead of the Evolution and Cancer Biology Laboratory, have reported the genetic events involved in the early development of bowel cancer in patients with inflammatory bowel disease (IBD). Such knowledge may be able to be exploited to design simple diagnostic tests to stratify patients with IBD at high risk of developing cancer.

Read more

Prof Trevor Graham part of ‘ACE’ research centre within NCI’s Cancer Systems Biology Consortium

19th June 2018

BCI’s Prof Trevor Graham, Lead of the Evolution and Cancer Biology Laboratory, is part of Arizona State University (ASU)’s recently funded research centre called ‘ACE’ (the Arizona Cancer Evolution Centre), which has been awarded more than $8.5 million over five years to serve as one of 13 research hubs within the National Cancer Institute (NCI)’s Cancer Systems Biology Consortium (CSBC). 

Read more

Search News
Categories
Archives
© 2013 ~ 2022 Cancer Research UK Barts Centre